Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NODAGA-RGD PET/CT for Tumoral Neoangiogenesis
NCT02666547Phase 1Terminated
- Sponsor
- Lausanne University Hospital
- Start
- Mar 2014
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Lausanne University Hospital. Primary endpoint: Comparison of each method of imaging for detection of tumors at 10 days. Started Mar 2014; status: terminated.
Beyond the preview
Go deeper on NCT02666547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666547.